Apollo Athenaa Women’s Cancer Centre is leading a shift towards earlier and more accurate breast cancer diagnosis through MRI-Guided Vacuum-Assisted Breast Biopsy (MRI-Guided VABB). This specialised, expertise-led, minimally invasive diagnostic technique allows doctors to identify and confirm breast cancer at early stage often at Stage 0 and Stage 1, when it is still small, symptom-free, and highly treatable. 
Studies indicate 10-20% cancers can be missed on mammograms and this number can further increase in dense breast. These undetected cancers often continue to grow silently without a lump, without symptoms, and beyond the reach of conventional screening tools. This challenge is especially significant in India, where younger women are increasingly being diagnosed with aggressive breast cancer often nearly a decade earlier than women in Western countries. Unfortunately, many of these cancers are still detected at advanced stages, when treatment becomes more aggressive, less effective with poorer outcomes. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Group, said, “At Apollo Athenaa, Asia’s first dedicated Women’s Cancer Centre, the launch of advanced MRI-Guided Vacuum-Assisted Breast Biopsy (MRI-Guided VABB) marks a transformative leap in women’s cancer care. This initiative strengthens the entire breast diagnostic pathway with greater precision, speed and clinical confidence, helping detect breast cancer earlier and enabling timely, minimally invasive intervention. Above all, it reflects our commitment to give every woman the best chance for excellent outcomes, greater reassurance, and the ability to move forward with confidence and dignity.”